Sensys's device is able to read blood glucose levels an unlimited number of times a day via near-infrared spectrometry

NOVEMBER 21, 2008 -- Sensys Medical (Chandler, AZ), developer of non-invasive blood glucose monitoring technology, is relocating its world headquarters to the UK according to UK Trade and Investment. Sensys's device is able to read blood glucose levels an unlimited number of times a day via near-infrared spectrometry, and is expected to greatly enhance diabetes management.

Read More

Retrieved November 21, 2008 from http://www.bioopticsworld.com/